All Stories

  1. Addiction care outcomes between insured and state opioid response grant-funded patients in a medicaid non-expansion state
  2. Trends in the use of opioid and non-opioid analgesics after TBI with and without polytrauma
  3. Comparative effectiveness of buprenorphine adherence with telemedicine vs. in-person for rural and urban patients
  4. Nonprescribed Substance Use in the General Hospital: A Retrospective Study
  5. Opioid analgesic and antidepressant use during pregnancy and the risk of spontaneous preterm birth: A nested case–control study
  6. Sex and Gender Variables in Data Set Creation and Data Cleaning for Inclusive and Accurate Reproductive Health Research and Quality Improvement
  7. Opioid and non-opioid analgesic regimens after fracture and risk of serious opioid-related events
  8. The impact of different strategies for modeling associations between medications at low doses and health outcomes: a simulation study and practical application to postpartum opioid use
  9. Performance of Phenotype Algorithms for the Identification of Opioid-Exposed Infants
  10. Impact of inpatient addiction psychiatry consultation on opioid use disorder outcomes
  11. Prescription Opioid Exposure During Pregnancy and Risk of Spontaneous Preterm Delivery
  12. Descriptive epidemiology of sickle cell disease in Tennessee: population-based estimates from 2008 to 2019
  13. Changes in medication initiation and selection patterns for gestational diabetes management
  14. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality
  15. Social Vulnerability and Initiation of Pharmacotherapy for Gestational Diabetes Mellitus in a Medicaid Population
  16. Response to Rezahosseini and Barrella Harboe
  17. Risk of Acute Myocardial Infarction Among Patients With Laboratory-Confirmed Invasive Pneumococcal Disease: A Self-Controlled Case Series Study
  18. Burden of all-cause and organism-specific parapneumonic empyema hospitalization rates prior to the SARS-CoV-2 pandemic in the United States
  19. Risk of Death at 1 Year Following Postpartum Opioid Exposure
  20. The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA
  21. The risk of serious opioid-related events associated with common opioid prescribing regimens in the postpartum period after cesarean delivery
  22. Prescription Opioid Dose After Vaginal Delivery and the Risk of Serious Opioid-Related Events: A Retrospective Cohort Study
  23. Variation in discharge opioid prescribing after vaginal births
  24. Diabetes medication regimens and patient clinical characteristics in the national patient‐centered clinical research network, PCORnet
  25. Opioid Prescribing After Childbirth and Risk for Serious Opioid-Related Events: A Cohort Study
  26. Social Distancing Measures: Evidence of Interruption of Seasonal Influenza Activity and Early Lessons of the SARS-CoV-2 Pandemic
  27. 60: Large variation in discharge opioid prescribing following vaginal births across hospitals in Tennessee
  28. Response to Boettiger
  29. To boost or not to boost? Lessons from the Australian pneumococcal conjugate vaccination program
  30. 1643-P: Prevalence of Diabetes Medication Regimens in PCORnet, the National Patient-Centered Clinical Research Network
  31. Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
  32. Changes in otitis media episodes and pressure equalization tube insertions among young children following introduction of the 13-valent pneumococcal conjugate vaccine: A birth-cohort based study
  33. Performance of a computable phenotype for identification of patients with diabetes within PCORnet: The Patient-Centered Clinical Research Network
  34. 277: Postpartum opioid prescribing and the risk of persistent opioid use
  35. Delivery type, opioid prescribing, and the risk of persistent opioid use after delivery
  36. Long-acting Opioid Use and the Risk of Serious Infections: A Retrospective Cohort Study
  37. Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases
  38. The use of prescribed opioid pain relievers and the risk of infections
  39. Validation of discharge diagnosis codes to identify serious infections among middle age and older adults
  40. Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases
  41. 769: Patterns of opioid use by trimester in pregnancy
  42. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era
  43. Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines
  44. Opioid Analgesics and the Risk of Serious Infections Among Patients With Rheumatoid Arthritis: A Self-Controlled Case Series Study
  45. Notes from the Field: Hepatitis C Outbreak in a Dialysis Clinic — Tennessee, 2014
  46. Collaborative Public Health Response during a Scabies Outbreak
  47. Fungal Infections Associated with Contaminated Methylprednisolone Injections
  48. Associations between ambient air pollution and prevalence of stroke and cardiovascular diseases in 33 Chinese communities
  49. Multistate Outbreak of Fungal Infection Associated with Injection of Methylprednisolone Acetate Solution from a Single Compounding Pharmacy—United States, 2012
  50. Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee
  51. Multistate Outbreak of Fungal Infection Associated With Injection of Methylprednisolone Acetate Solution From a Single Compounding Pharmacy—United States, 2012